Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
NCT00172029
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer With Metastatic Bone Disease
Interventions
DRUG:
Zoledronic acid
Sponsor
Novartis